The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AADI BIOSCIENCES INC COM 00032Q104 36,935 1,529,402 SH   SOLE   1,529,402 0 0
ACLARIS THERAPEU COM 00461U105 1,425 98,000 SH   SOLE   98,000 0 0
ALDEYRA THERAPEUTICS INC COM 01438T106 2,000 500,000 SH   SOLE   500,000 0 0
ALPINE IMMUNE SCIENCES INC COM 02083G100 3,186 230,000 SH   SOLE   230,000 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 25,295 535,000 SH   SOLE   535,000 0 0
ARROWHEAD PHARMACEUTICALS INC COM 04280A100 6,995 105,500 SH   SOLE   105,500 0 0
ATHIRA PHARMA INC COM 04746L104 4,040 310,030 SH   SOLE   310,030 0 0
AVADEL PHARMACEUTICALS PLC SPONSORED ADR 999222ZZ8 4,686 580,000 SH   SOLE   580,000 0 0
BCLS ACQUISITION CORP- CL A COM CL A G0904B105 8,263 843,122 SH   SOLE   843,122 0 0
BELLUS HEALTH INC COM NEW 07987C204 4,226 525,000 SH   SOLE   525,000 0 0
CELLDEX THERAPEUTICS INC COM NEW 15117B202 13,141 340,098 SH   SOLE   340,098 0 0
CYTEIR THERAPEUTICS INC COM 23284P103 4,457 391,974 SH   SOLE   391,974 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 2,975 243,072 SH   SOLE   243,072 0 0
FULCRUM THERAPEUTICS INC COM 359616109 3,538 200,000 SH   SOLE   200,000 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106 9,790 419,632 SH   SOLE   419,632 0 0
GOSSAMER BIO INC COM 38341P102 1,355 119,843 SH   SOLE   119,843 0 0
GALERA THERAPEUTICS INC COM 36338D108 1,205 262,500 SH   SOLE   262,500 0 0
HEALTH SCIENCES ACQUISITIONS ORD SHS G4411D109 3,956 392,500 SH   SOLE   392,500 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 3,436 179,995 SH   SOLE   179,995 0 0
IVERIC BIO INC COM 46583P102 7,858 470,000 SH   SOLE   470,000 0 0
JOUNCE THERAPEUTICS INC COM 481116101 1,065 127,500 SH   SOLE   127,500 0 0
JIYA ACQUISITION CORP -CL A COM CL A 47760M102 5,496 562,500 SH   SOLE   562,500 0 0
KURA ONCOLOGY INC. COMMON STOCK COM 50127T109 4,086 291,884 SH   SOLE   291,884 0 0
MIRATI THERAPEUTICS COM 60468T105 2,934 20,000 SH   SOLE   20,000 0 0
MERUS BV COM N5749R100 7,489 235,500 SH   SOLE   235,500 0 0
MOLECULAR TEMPLATES INC COM 608550109 1,264 322,500 SH   SOLE   322,500 0 0
Nuvation Warrants *W EXP 07/07/202 67080N101 172 90,832 SH   SOLE   90,832 0 0
PYXIS ONCOLOGY INC SERIES B COMMON STOCK 747324101 7,435 677,753 SH   SOLE   677,753 0 0
RELMADA THERAPEUTICS INC COM 75955J402 9,102 404,000 SH   SOLE   404,000 0 0
SEELOS THERAPEUTICS INC COM 81577F109 4,075 2,500,000 SH   SOLE   2,500,000 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 4,512 206,126 SH   SOLE   206,126 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 1,489 68,500 SH   SOLE   68,500 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104 6,287 318,000 SH   SOLE   318,000 0 0
VERASTEM INC COM 92337C104 3,823 1,865,000 SH   SOLE   1,865,000 0 0
VISTAGEN THERAPEUTICS INC COM NEW 92840H202 22,886 11,736,283 SH   SOLE   11,736,283 0 0
XENON PHARMACEUTICALS INC COM 98420N105 7,029 225,000 SH   SOLE   225,000 0 0